Sharmila Makhija - Concepedia

Author

Sharmila Makhija

University of Alabama at Birmingham ORCID

Also Known As

S K Makhija, S MAKHIJA, S Makhija, S. K. Makhija, S. Makhija, S.K. Makhija, SK Makhija, Sharmila K Makhija, Sharmila K. Makhija, Sharmila Makhija

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham Howard Hughes Medical Institute Kyushu University Memorial Sloan Kettering Cancer Center Gynecologic Oncology Group

About

Sharmila Makhija is an author at University of Alabama at Birmingham specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	837
2	Cell Biology	9	9	530
3	Public Health	1	1	17
4	Cellular Physiology	1	1	47
5	General Surgery	1	1	98

Sharmila Makhija

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers Rasha Khoury, Peter S. Bernstein, Chelsea A. DeBolt, Obstetrics and Gynecology	2020	213
Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Sharmila Makhija, Lukas C. Amler, D. Glenn, Journal of Clinical Oncology	2009	180
Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway Toshiaki Ohtsuka, Donald J. Buchsbaum, Patsy G. Oliver, Oncogene Tumor BiologyTumor Cell ApoptosisApoptosisImmunologyMitochondrial Death Pathway	2003	159
Transcriptional targeting of tumors with a novel tumor-specific survivin promoter Zeng B. Zhu, Sharmila Makhija, Baogen Lu, Cancer Gene Therapy Tumor BiologyTranscriptional RegulationOncogenic AgentMedicineTranscriptional Targeting	2004	104
Complications Associated with Intraperitoneal Chemotherapy Catheters Sharmila Makhija, Mario M. Leitão, Paul Sabbatini, Gynecologic Oncology MedicinePatient SafetySurgeryGeneral SurgeryIntraperitoneal Chemotherapy Catheters	2001	98
Inducible Resistance of Tumor Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2–Mediated Apoptosis by Generation of a Blockade at the Death Domain Function Yang Li, Hong Wang, Zheng Wang, Cancer Research	2006	61
Evaluation of tumor-specific promoter activities in melanoma Baogen Lu, Sharmila Makhija, Dirk M. Nettelbeck, Gene Therapy MedicineMelanomaTumor-specific Promoter ActivitiesGene ExpressionCancer Biology	2005	53
Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids. Sharmila Makhija, Douglas D. Taylor, Randall K. Gibb, International Journal of Oncology ApoptosisPathologyCell DeathBax ExpressionCancer Biology	1999	51
Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis Zeng B. Zhu, Sharmila Makhija, Baogen Lu, Virology Caco-2 CellsPolarized MonolayerSignal TransductionMembrane TransportCell Trafficking	2004	47
Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo Zeng B. Zhu, Sharmila Makhija, Baogen Lu, International Journal of Oncology Viral ReplicationSurvivin PromoterImmunologyCancer BiologyTumor Specificity	2005	46

Page 1